<DOC>
	<DOCNO>NCT00308776</DOCNO>
	<brief_summary>This study determine effectiveness administrate dose cholecystokinin binge eat episode reduce eating behavior people bulimia nervosa .</brief_summary>
	<brief_title>Cholecystokinin Reducing Binge Eating People With Bulimia Nervosa</brief_title>
	<detailed_description>Bulimia Nervosa ( BN ) serious eat disorder characterize frequent uncontrolled eating binge . These binge often follow compensatory behavior , include follow : self-induced vomiting ; misuse laxative , diuretic , enema , medication induce purge ; fast ; excessive exercise . If leave untreated , BN lead many serious health issue : tooth decay ; irregular menstruation ; bowel damage ; constipation ; heart kidney disease ; intestinal damage ; puffiness , especially face finger ; increase hair growth face body ; mineral imbalance body . Cholecystokinin ( CCK ) hormone release small intestine , function trigger digestion hunger suppression . People BN often disturbances release CCK , may contribute binge eat behavior . This study determine effectiveness administrate dose CCK binge eat episode reduce eating behavior people BN . This study enroll female BN healthy female without BN . Interested participant first report study site interview feeling eat habit . If eligible , participant report study site 9 A.M. 4 day . Upon arrival , receive standardize breakfast apple juice English muffin butter . Participants return 2.5 hour later start IV begin infusion normal saline solution . After 10 minute saline infusion , participant eat small bowl tomato soup , follow 20 minute later 15-minute infusion either saline saline plus CCK . Participants give meal macaroni beef . They alone room eating , monitor TV camera . Nothing , however , tap record . A tape record use instruct participant begin eat . Participants instruct either eat assistant return room , eat much . Participants also fill questionnaire meal , sometimes meal . The amount food consume infusion CCK assess upon study completion . For information relate study , please follow link : http : //clinicaltrials.gov/show/NCT00307190 http : //clinicaltrials.gov/show/NCT00304187</detailed_description>
	<mesh_term>Feeding Eating Disorders</mesh_term>
	<mesh_term>Bulimia</mesh_term>
	<mesh_term>Binge-Eating Disorder</mesh_term>
	<mesh_term>Bulimia Nervosa</mesh_term>
	<mesh_term>Cholecystokinin</mesh_term>
	<criteria>Inclusion Criteria Patients BN : Meets DSMIV criterion BN BN duration 1 year Selfinduces vomit Weighs 80 120 % ideal body weight Exclusion Criteria Patients BN : Significant medical illness Current lifetime history schizophrenia , bipolar disorder , psychotic disorder , define DSMIVTR criterion Current DSMIVTR diagnosis organic mental disorder , factitious disorder , malinger History personality disorder ( e.g. , schizotypal , borderline , antisocial ) might interfere study procedure At risk suicide , define expression imminent plan attempt within 6 month prior study entry Currently take psychotropic medication medication affect gastrointestinal function Moderate severe depression , define score great 28 Hamilton Depression Rating Scale Drug alcohol abuse within 3 month prior study entry Pregnant , plan become pregnant , lactate Body mass index ( BMI ) less 18 ( underweight ) Inclusion Criteria Normal Weight Controls : No current past psychiatric history No history binge eat vomit 80120 % ideal body weight Exclusion Criteria Normal Weight Controls : Significant medical illness Current psychotropic medication current medication affect GI function Drug alcohol abuse last 3 month Pregnancy , plan become pregnant laction</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>May 2012</verification_date>
</DOC>